Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Achen

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|April 5, 1991
The distribution of cerebral expression of the transferrin gene is species specificG F Tu, M G Achen, A R Aldred, et al.
The American Journal of Physiology|February 1, 1990
Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexusG Schreiber, A R Aldred, A Jaworowski, et al.
The Journal of Biological Chemistry|September 28, 2001
Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysisM E Baldwin, S Roufail, M M Halford, et al.
The Journal of Biological Chemistry|November 15, 1992
Protein synthesis at the blood-brain barrier. The major protein secreted by amphibian choroid plexus is a lipocalinM G Achen, P J Harms, T Thomas, et al.
European Journal of Biochemistry|September 15, 1991
Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Implications for the evolution of structure and function of transthyretin in vertebratesW Duan, M G Achen, S J Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 1998
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)M G Achen, M Jeltsch, E Kukk, et al.
Molecular Medicine (Cambridge, Mass.)|January 10, 2002
VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiformeW Debinski, B Slagle-Webb, M G Achen, et al.
The Journal of Biological Chemistry|November 27, 1999
A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeabilityS A Stacker, A Vitali, C Caesar, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissuesT A Partanen, J Arola, A Saaristo, et al.
British Journal of Cancer|May 14, 2009
Elevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancerP Balanathan, E D Williams, H Wang, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|April 5, 1991
The distribution of cerebral expression of the transferrin gene is species specificG F Tu, M G Achen, A R Aldred, et al.
The American Journal of Physiology|February 1, 1990
Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexusG Schreiber, A R Aldred, A Jaworowski, et al.
The Journal of Biological Chemistry|September 28, 2001
Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysisM E Baldwin, S Roufail, M M Halford, et al.
The Journal of Biological Chemistry|November 15, 1992
Protein synthesis at the blood-brain barrier. The major protein secreted by amphibian choroid plexus is a lipocalinM G Achen, P J Harms, T Thomas, et al.
European Journal of Biochemistry|September 15, 1991
Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Implications for the evolution of structure and function of transthyretin in vertebratesW Duan, M G Achen, S J Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 1998
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)M G Achen, M Jeltsch, E Kukk, et al.
Molecular Medicine (Cambridge, Mass.)|January 10, 2002
VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiformeW Debinski, B Slagle-Webb, M G Achen, et al.
The Journal of Biological Chemistry|November 27, 1999
A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeabilityS A Stacker, A Vitali, C Caesar, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissuesT A Partanen, J Arola, A Saaristo, et al.
British Journal of Cancer|May 14, 2009
Elevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancerP Balanathan, E D Williams, H Wang, et al.
Pageof 4